Clinical Trial Update: Induction of Donor Specific Tolerance in Recipients of Live Donor Kidney Allografts by Donor Stem Cell Infusion [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating donor stem cell infusion to induce donor-specific tolerance in recipients of live donor kidney allografts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection
• Renal Failure

Drugs mentioned

• Donor stem cell infusion

Snippet

Sponsor: Talaris Therapeutics Inc. | Conditions: Renal Failure | Phase 1, Phase 2 | Status: UNKNOWN